1. Propofol prevents IL‐13‐induced epithelial–mesenchymal transition in human colorectal cancer cells
    Kejia Xu et al, 2018, Cell Biology International CrossRef
  2. Comprehensive Transcriptome Analysis Reveals the Distinct Gene Expression Patterns of Tumor Microenvironment in HPV-Associated and HPV-Non Associated Tonsillar Squamous Cell Carcinoma
    Reham M. Alahmadi et al, 2023, Cancers CrossRef
  3. Interleukins 4 and 13 and Their Receptors Are Differently Expressed in Gastrointestinal Tract Cancers, Depending on the Anatomical Site and Disease Advancement, and Improve Colon Cancer Cell Viability and Motility
    Iwona Bednarz-Misa et al, 2020, Cancers CrossRef
  4. A diversity of novel type-2 innate lymphoid cell subpopulations revealed during tumour expansion
    Clara Wenjing Xia et al, 2024, Communications Biology CrossRef
  5. Interleukin-4 and interleukin-13 increase NADPH oxidase 1-related proliferation of human colon cancer cells
    Han Liu et al, 2017, Oncotarget CrossRef
  6. Combining 1,4-dihydroxy quininib with Bevacizumab/FOLFOX alters angiogenic and inflammatory secretions in ex vivo colorectal tumors
    Susan A. Kennedy et al, 2020, BMC Cancer CrossRef
  7. Lack of STAT6 Attenuates Inflammation and Drives Protection against Early Steps of Colitis-Associated Colon Cancer
    Sonia A. Leon-Cabrera et al, 2017, Cancer Immunology Research CrossRef
  8. Can anIL13-1112 C/T (rs1800925) polymorphism predict responsiveness to neoadjuvant chemoradiotherapy and survival of Chinese Han patients with locally advanced rectal cancer?
    Lin Xiao et al, 2016, Oncotarget CrossRef
  9. Innate lymphoid cells and cancer at border surfaces with the environment
    Irene Mattiola et al, 2019, Seminars in Immunology CrossRef
  10. PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions
    Giuseppe Ercolano et al, 2021, Nature Communications CrossRef
  11. Peripheral Innate Lymphoid Cells Are Increased in First Line Metastatic Colorectal Carcinoma Patients: A Negative Correlation With Th1 Immune Responses
    Romain Loyon et al, 2019, Frontiers in Immunology CrossRef
  12. A novel type-2 innate lymphoid cell-based immunotherapy for cancer
    Iryna Saranchova et al, 2024, Frontiers in Immunology CrossRef
  13. The expanding role of innate lymphoid cells and their T-cell counterparts in gastrointestinal cancers
    Ka Yee Fung et al, 2019, Molecular Immunology CrossRef
  14. Macrophage depletion using clodronate liposomes decreases tumorigenesis and alters gut microbiota in the AOM/DSS mouse model of colon cancer
    Jackie E. Bader et al, 2018, American Journal of Physiology-Gastrointestinal and Liver Physiology CrossRef
  15. Natural killer cells and other innate lymphoid cells in cancer
    Laura Chiossone et al, 2018, Nature Reviews Immunology CrossRef
  16. Enzyme-linked immunospot assay to monitor antigen-specific cellular immune responses in mouse tumor models
    Donatella Negri et al, 2020, Tumor Immunology and Immunotherapy – Cellular Methods Part B CrossRef
  17. Progression or suppression: Two sides of the innate lymphoid cells in cancer
    S. Haleh Hosseini et al, 2020, Journal of Cellular Biochemistry CrossRef
  18. ILC in chronic inflammation, cancer and targeting with biologicals
    Claudia De Pasquale et al, 2021, Molecular Aspects of Medicine CrossRef
  19. Differential effects of peptidoglycan on colorectal tumors and intestinal tissue post-pelvic radiotherapy
    Gen Li et al, 2016, Oncotarget CrossRef
  20. Innate Lymphoid Cells: Expression of PD-1 and Other Checkpoints in Normal and Pathological Conditions
    Francesca Romana Mariotti et al, 2019, Frontiers in Immunology CrossRef
  21. Role of Inflammation in the Development of Colorectal Cancer
    Sridhar Muthusami et al, 2021, Endocrine, Metabolic & Immune Disorders - Drug Targets CrossRef
  22. Homo and heterobimetallic palladium and platinum complexes bearing μ-diphosphane bridges involved in biological studies
    Talita Kuijpers et al, 2021, European Journal of Medicinal Chemistry CrossRef
  23. New Insights on Pseudomonas Aeruginosa Exotoxin A-based Immunotoxins in Targeted Cancer Therapeutic Delivery
    Radwa N Morgan et al, 2023, Therapeutic Delivery CrossRef